Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PLG 0206

Next Previous
Drug Profile

PLG 0206

Alternative Names: Antimicrobial peptides - Peptilogics; eCAPS - Peptilogics; engineered Cationic Antimicrobial Peptides - Peptilogics; PLG-0206

Latest Information Update: 13 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Peptilogics
  • Class Anti-infectives; Antibacterials; Antimicrobial cationic peptides
  • Mechanism of Action Bacterial biofilm inhibitors; Cell membrane permeability enhancers; Cell membrane structure modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Bone and joint infections
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Bacterial infections; Bone and joint infections

Most Recent Events

  • 13 Aug 2024 Phase I development is ongoing in Australia(ACTRN12618001920280) (Peptilogics pipeline, August 2024)
  • 13 Aug 2024 Peptilogics initiates preclinical trial for other Bone and joint infections in USA before August 2024 (Peptilogics pipeline, August 2024)
  • 19 Mar 2024 Peptilogics completes a phase I trials in Bone and joint infections in USA (unspecified route) (NCT05137314)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top